Claims for Patent: 8,406,860

Summary for Patent: 8,406,860

Title:	Method for evaluating blush in myocardial tissue
Abstract:	Vessel perfusion and myocardial blush are determined by analyzing fluorescence signals obtained in a static region-of-interest (ROI) in a collection of fluorescence images of myocardial tissue. The blush value is determined from the total intensity of the intensity values of image elements located within the smallest contiguous range of image intensity values containing a predefined fraction of a total measured image intensity of all image elements within the ROI. Vessel (arterial) peak intensity is determined from image elements located within the ROI that have the smallest contiguous range of highest measured image intensity values and contain a predefined fraction of a total measured image intensity of all image elements within the ROI. Cardiac function can be established by comparing the time differential between the time of peak intensity in a blood vessel and that in a region of neighboring myocardial tissue both pre and post procedure.
Inventor(s):	Dvorsky; Peter (Toronto, CA), Goyette; David Mark Henri (Mississauga, CA), Ferguson, Jr.; T. Bruce (Raleigh, NC), Chen; Cheng (Greenville, NC)
Assignee:	Novadaq Technologies Inc. (Mississauga, CA)
Application Number:	12/841,659
Patent Claims:	1. A method for intraoperatively assessing blood flow in surgical flaps and identifying vascular compromise, comprising the steps of: defining a static region of interest (ROI) in an image of a surgical flap; detecting a fluorescence response from tissue following application of a bolus of ICG into the bloodstream; measuring, on one of native tissue adjacent the ROI and a surgical flap pre-operatively associated with the ROI, a first rate of change of increasing perfusion of ICG with time until a determined maximum fluorescence is reached; measuring, on the surgical flap post-operatively associated with the ROI, a second rate of change of increasing perfusion of ICG with time until a determined maximum fluorescence is reached; measuring, on one of native tissue adjacent the ROI and the surgical flap pre-operatively associated with the ROI, a first rate of change of decreasing perfusion of ICG with time after the determined maximum fluorescence is reached; measuring, on the surgical flap post-operatively associated with the ROI, a second rate of change of decreasing perfusion of ICG with time after the determined maximum fluorescence is reached; and determining a degree of vascular compromise at the ROI from at least one of a ratio between said first rate of change of increasing perfusion and said second rate of change of increasing perfusion, and a ratio between said first rate of change of decreasing perfusion and said second rate of change of decreasing perfusion.